Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xtant Medical Holdings (XTNT) Other Working Capital Changes (2016 - 2025)

Xtant Medical Holdings (XTNT) has disclosed Other Working Capital Changes for 16 consecutive years, with $33000.0 as the latest value for Q3 2025.

  • Quarterly Other Working Capital Changes fell 2.94% to $33000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$599000.0 through Sep 2025, down 270.17% year-over-year, with the annual reading at $218000.0 for FY2024, 199.09% up from the prior year.
  • Other Working Capital Changes for Q3 2025 was $33000.0 at Xtant Medical Holdings, up from -$67000.0 in the prior quarter.
  • The five-year high for Other Working Capital Changes was $376000.0 in Q1 2024, with the low at -$543000.0 in Q2 2022.
  • Average Other Working Capital Changes over 5 years is -$26842.1, with a median of $33000.0 recorded in 2025.
  • The sharpest move saw Other Working Capital Changes plummeted 586.36% in 2023, then skyrocketed 452.94% in 2024.
  • Over 5 years, Other Working Capital Changes stood at -$59000.0 in 2021, then skyrocketed by 62.71% to -$22000.0 in 2022, then tumbled by 586.36% to -$151000.0 in 2023, then plummeted by 88.74% to -$285000.0 in 2024, then surged by 111.58% to $33000.0 in 2025.
  • According to Business Quant data, Other Working Capital Changes over the past three periods came in at $33000.0, -$67000.0, and -$280000.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.